DOCS vs JNJ · P/E 21, rev $570.4M vs P/E 17, rev $49.37B
Doximity Inc (DOCS) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Doximity Inc (DOCS) is a health information services company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
DOCS currently screens at market cap $3.77B and trailing P/E 21.0. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the DOCS and JNJ stock pages for the full models.
Not investment advice.